News

Amidst a pipeline bulging with oncology bets, GlaxoSmithKline has invested $120 million in a new biologics plant. The announcement was made by Emma Walmsley, CEO, at the drugmaker’s manufacturing site at Upper Merion, Pennsylvania. According to her, the investment...

World Pharma Today / News / India - Eywa Pharma, founded by two former Mylan employees and backed by Eight Roads ventures has plans to expand in the US and EU markets with a portfolio of specific competition products....

World Pharma Today / News / India - Mylan, a global generic and specialty Pharmaceuticals Company registered in the Netherlands has confirmed that in the coming 5-6 years it will invest one billion USD on Capex in India. The...

The clinical-stage biopharmaceutical company Acceleron Pharma Inc. has announced the discontinuation of the development of drug for facioscapulohumeral muscular dystrophy (FSHD), ACE-083. Further clinical trials will not be conducted in this arena as the drug could not achieve statistically...

Sharp, part of UDG Healthcare and a leading provider of clinical supply services, has strengthened its leadership team with the appointment of Sascha Sonnenberg as global head of business development for Sharp Clinical Services. Mr. Sonnenberg joins Sharp from Marken...

Following the Indian Government’s surprise move to cut corporate tax rates, USV Pvt.Ltd., an Indian multinational Pharma and Biotech company has announced that it will proceed with the investment on a new formulation plant in Vadodara, India. The Indian...

Pharmaceutical Product Development, LLC (PPD), is expanding its bioanalytical laboratory in Richmond, Virginia, enhancing its ability to provide industry-leading capabilities to meet biopharmaceutical clients’ increasing research needs. The expansion of the lab’s immunochemistry, biomarker and chromatography services builds on PPD’s...